Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Carvedilol-d5
Price:
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang

929106-58-1

929106-58-1 structure

Name: Carvedilol-d5
Chemical Name: 1-(9H-carbazol-4-yloxy)-1,1,2,3,3-pentadeuterio-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
CAS Number: 929106-58-1
Molecular Formula: C₂₄H₂₁D₅N₂O₄
Molecular Weight: 411.51
Catalog: Signaling Pathways Autophagy Autophagy
Create Date: 2017-05-30 13:59:41
Modify Date: 2024-01-08 16:39:10
Carvedilol-d5 is deuterium labeled Carvedilol. Carvedilol (BM 14190) is a non-selective β/α-1 blocker[1]. Carvedilol inhibits lipid peroxidation in a dose-dependent manner with an IC50 of 5 μM. Carvedilol is a multiple action antihypertensive agent with potential use in angina and congestive heart failure[2]. Carvedilol is an autophagy inducer that inhibits the NLRP3 inflammasome[3].

Name	1-(9H-carbazol-4-yloxy)-1,1,2,3,3-pentadeuterio-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
Synonyms	2-Propan-1,1,2,3,3-d5-ol,1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino] [2H5]-Carvedilol

Description	Carvedilol-d5 is deuterium labeled Carvedilol. Carvedilol (BM 14190) is a non-selective β/α-1 blocker[1]. Carvedilol inhibits lipid peroxidation in a dose-dependent manner with an IC50 of 5 μM. Carvedilol is a multiple action antihypertensive agent with potential use in angina and congestive heart failure[2]. Carvedilol is an autophagy inducer that inhibits the NLRP3 inflammasome[3].
Related Catalog	Research Areas >> Cancer Research Areas >> Cardiovascular Disease Signaling Pathways >> Autophagy >> Autophagy Signaling Pathways >> GPCR/G Protein >> Adrenergic Receptor Research Areas >> Inflammation/Immunology
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Eggertsen R, et al. Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients. Eur J Clin Pharmacol. 1984;27(1):19-22. [3]. Feuerstein GZ, et al. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity. J Hypertens Suppl. 1993 Jun;11(4):S41-8. [4]. Wong WT, et al. Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome. Front Immunol. 2018 Aug 22;9:1920.

Molecular Formula	C₂₄H₂₁D₅N₂O₄
Molecular Weight	411.51
Exact Mass	411.22100
PSA	75.74000
LogP	4.12890

929106-58-1	1329792-68-8
1329836-56-7	2673270-31-8
1261395-96-3	374779-43-8
610309-89-2	216973-69-2
216973-70-5	72956-09-3
2377611-52-2	1229741-71-2
2310017-82-2	2469036-39-1
251946-99-3	1935316-01-0
1270544-89-2	1823067-49-7
2361882-79-1	1882077-28-2